Net revenue grew 11% to $915.5 million, with adjusted EBITDA up 11% to $61.1 million. The company expanded globally through the BrewDog and Lyphe acquisitions, improved margins via cost-saving initiatives, and maintained strong liquidity. Risks include regulatory uncertainty, competition, and suppl…
Net revenue grew 11% to $915.5 million, with adjusted EBITDA up 11% to $61.1 million. The company expanded globally through the BrewDog and Lyphe acquisitions, improved margins via cost-saving initiatives, and maintained strong liquidity. Risks include regulatory uncertainty, competition, and supply chain pressures.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
